Skip to main content
editorial
. 2006 Nov 7;12(41):6693–6698. doi: 10.3748/wjg.v12.i41.6693

Figure 1.

Figure 1

Clinical courses of HBeAg positive chronic hepatitis B patients who were treated more than 36 mo among 136 patients in decrescendo group at 9 mo of lamivudine treatment. Decrescendo pattern, continuously decreasing HBeAg levels by more than 90% of pretreatment values over time; Decrescendo-crescendo pattern: continuous decrease by more than 90% of pretreatment values, and then progressively increasing.